← 返回

NaCl 增强癌症免疫治疗中 CD8(+) T 细胞效应功能

英文原题:NaCl enhances CD8(+) T cell effector functions in cancer immunotherapy.

查看英文原题

NaCl enhances CD8(+) T cell effector functions in cancer immunotherapy.

PubMed 2024/08/28(内容时间) Nat Immunol Q1 · IF 26.5(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

CD8+ T细胞能够控制肿瘤,但在肿瘤微环境中不可避免地会变得功能失调。在此,我们表明氯化钠(NaCl)能够对抗T细胞功能失调,从而促进癌症消退。在CD8+ T细胞培养过程中补充NaCl可诱导效应分化、IFN-γ产生和细胞毒性,同时维持负责干性可塑性的基因网络。相应地,在人性化小鼠模型中,过继转移肿瘤特异性T细胞产生了更强的抗肿瘤免疫。在小鼠中,高盐饮食以CD8+ T细胞依赖的方式抑制了实验性肿瘤的生长,其机制是抑制终末分化并增强CD8+ T细胞的效应效力。在机制上,NaCl增强了谷氨酰胺消耗,而这对转录、表观遗传和功能重编程至关重要。在人类中,肿瘤中经历抗原识别并预测对检查点阻断免疫治疗有利反应的CD8+ T细胞,与NaCl诱导的CD8+ T细胞相似。因此,NaCl代谢是CD8+ T细胞效应功能的调节因子,对癌症免疫治疗具有潜在意义。

展开英文摘要原文

CD8 + T cells control tumors but inevitably become dysfunctional in the tumor microenvironment.

Here, we show that sodium chloride (NaCl) counteracts T cell dysfunction to promote cancer regression. NaCl supplementation during CD8 + T cell culture induced effector differentiation, IFN-γ production and cytotoxicity while maintaining the gene networks responsible for stem-like plasticity.

Accordingly, adoptive transfer of tumor-specific T cells resulted in superior anti-tumor immunity in a humanized mouse model. In mice, a high-salt diet reduced the growth of experimental tumors in a CD8 + T cell-dependent manner by inhibiting terminal differentiation and enhancing the effector potency of CD8 + T cells.

Mechanistically, NaCl enhanced glutamine consumption, which was critical for transcriptional, epigenetic and functional reprogramming. In humans, CD8 + T cells undergoing antigen recognition in tumors and predicting favorable responses to checkpoint blockade immunotherapy resembled those induced by NaCl.

Thus, NaCl metabolism is a regulator of CD8 + T cell effector function, with potential implications for cancer immunotherapy.

论文信息

作者
Scirgolea C、Sottile R、De Luca M、Susana A、Carnevale S、Puccio S、Ferrari V、Lise V
第一作者单位
IRCCS Humanitas Research Hospital, Milan, Italy.Italy
通讯作者单位
IRCCS Humanitas Research Hospital, Milan, Italy. enrico.lugli@humanitasresearch.it.Italy
期刊
Nature immunology2024 Oct
原文标识
PubMed 39198631 · DOI 10.1038/s41590-024-01923-9